Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Reneo Pharmaceuticals, Inc. | Chief Operating Officer | Common Stock | 35.8K | $224K | $6.28 | Dec 9, 2022 | Direct |
Reneo Pharmaceuticals, Inc. | Chief Operating Officer | Common Stock | 13.7K | $86K | $6.28 | Dec 9, 2022 | by Trust |
Reneo Pharmaceuticals, Inc. | Chief Operating Officer | Stock option (right to buy) | 125K | Dec 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPHM | Reneo Pharmaceuticals, Inc. | Dec 9, 2022 | 1 | $0 | 4 | Dec 13, 2022 | Chief Operating Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Sep 1, 2022 | 1 | $25.4K | 4 | Sep 2, 2022 | Chief Operating Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Aug 29, 2022 | 5 | $23.2K | 4 | Aug 31, 2022 | Chief Operating Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Mar 2, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Chief Operating Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Dec 10, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Senior VP-Corporate Operations |
RPHM | Reneo Pharmaceuticals, Inc. | Aug 25, 2021 | 1 | $18.6K | 4 | Aug 26, 2021 | Senior VP-Corporate Operations |